Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol

Biochemistry

Volumn 46, Issue 20, 2007, Pages 6050-6059

  Pécheur, Eve Isabelle ^a,g   Lavillette, Dimitri ^b,c   Alcaras, Fanny ^a   Molle, Jennifer ^a   Boriskin, Yury S ^d   Roberts, Michael ^e   Cosset, François Loïc ^b,c   Polyak, Stephen J ^f  

^a UNIVERSITÉ LYON 1   (France)

^b UNIVERSITÉ DE LYON   (France)

^c UNIVERSITÉ DE LYON   (France)

^d D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^e GLOBAL PHASING LTD   (United Kingdom)

^f UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^g INSTITUT DE BIOLOGIE ET CHIMIE DES PROTÉINES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRAL AGENTS; GENOTYPES; HEPATITIS C VIRUS; LIPID MEMBRANES;

BIOLOGICAL MEMBRANES; BIOMECHANICS; DRUG PRODUCTS; ENZYME INHIBITION; GLYCOPROTEINS; LIPIDS; PH;

VIRUSES;

ARBIDOL; DETERGENT; LIPOSOME;

ACIDITY; ARTICLE; DRUG MECHANISM; DRUG SCREENING; FLUORESCENCE; GENOTYPE; HEPATITIS C VIRUS; LIPID MEMBRANE; MEMBRANE FUSION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN MOTIF; VIRUS CELL INTERACTION; VIRUS INHIBITION;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; DETERGENTS; HEPACIVIRUS; HUMANS; INDOLES; LIPOSOMES; MEMBRANE FUSION; MEMBRANE LIPIDS; MICELLES; VIRION;

HEPATITIS C VIRUS;

EID: 34249101881     PISSN: 00062960     EISSN: None     Source Type: Journal    
DOI: 10.1021/bi700181j     Document Type: Article

References (48)

1. Di Bisceglie, A. M., Fan, X., Chambers, T., and Strinko, J. (2006) Pharmacokinetics, pharmacodynamics, and hepatitis C viral kinetics during antiviral therapy: The null responder, J. Med. Virol. 78, 446-451.
2. Lohmann, V., Korner, F., Koch, J., Herian, U., Theilmann, L., and Bartenschlager, R. (1999) Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line, Science 285, 110-113.
3. Horscroft, N., Lai, V. C., Cheney, W., Yao, N., Wu, J. Z., Hong, Z., and Zhong, W. (2005) Replicon cell culture system as a valuable tool in antiviral drug discovery against hepatitis C virus, Antiviral Chem. Chemother. 16, 1-12.
4. Paeshuyse, J., Kaul, A., De Clercq, E., Rosenwirth, B., Dumont, J. M., Scalfaro, P., Bartenschlager, R., and Neyts, J. (2006) The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro, Hepatology 43, 761-770.
5. Duong, F. H., Christen, V., Filipowicz, M., and Heim, M. H. (2006) S-Adenosylmethionine and betaine correct hepatitis C virus induced inhibition of interferon signaling in vitro, Hepatology 43, 796-806.
6. Anonymous (1999) Arbidol, Drugs R&D 2, 171-172.
7. Gagarinova, V. M., Ignat'eva, G. S., Sinitskaia, L. V., Ivanova, A. M., Rodina, M. A., and Tur'eva, A. V. (1993) (The new chemical preparation arbidol: Its prophylactic efficacy during influenza epidemics), Zh. Mikrobiol., Epidemiol. Immunobiol., 40-43.
8. Brooks, M. J., Sasadeusz, J. J., and Tannock, G. A. (2004) Antiviral chemotherapeutic agents against respiratory viruses: Where are we now and what's in the pipeline? Curr. Opin. Pulm. Med. 10, 197-203.
9. Chai, H., Zhao, Y., Zhao, C., and Gong, P. (2006) Synthesis and in vitro anti-hepatitis B virus activities of some ethyl 6-bromo-5-hydroxy-1H-indole-3- carboxylates, Bioorg. Med. Chem. 14, 911-917.
10. Fediakina, I. T., Leneva, I. A., Iamnikova, S. S., Livov, D. K., Glushkov, R. G., and Shuster, A. M. (2005) (Sensitivity of influenza A/H5 viruses isolated from wild birds on the territory of Russia to arbidol in the cultured MDCK cells), Vopr. Virusol. 50, 32-35.
11. Leneva, I. A., Fediakina, I. T., Gus'kova, T. A., and Glushkov, R. G. (2005) (Sensitivity of various influenza virus strains to arbidol. Influence of arbidol combination with different antiviral drugs on reproduction of influenza virus A), Ter. Arkh. 77, 84-88.
12. Boriskin, Y. S., Pécheur, E. I., and Polyak, S. J. (2006) Arbidol: A broad-spectrum antiviral that inhibits acute and chronic HCV infection, Virol. J. 3, 56.
13. Bartosch, B., Dubuisson, J., and Cosset, F. L. (2003) Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes, J. Exp. Med. 197, 633-642.
14. Hatziioannou, T., Valsesia-Wittmann, S., Russell, S. J., and Cosset, F. L. (1998) Incorporation of fowl plague virus hemagglutinin into murine leukemia virus particles and analysis of the infectivity of the pseudotyped retroviruses, J. Virol. 72, 5313-5317.
15. Sandrin, V., Boson, B., Salmon, P., Gay, W., Negre, D., Le Grand, R., Trono, D., and Cosset, F. L. (2002) Lentiviral vectors pseudotyped with a modified RD114 envelope glycoprotein show increased stability in sera and augmented transduction of primary lymphocytes and CD34+ cells derived from human and nonhuman primates, Blood 100, 823-832.
16. Lavillette, D., Bartosch, B., Nourrisson, D., Verney, G., Cosset, F. L., Penin, F., and Pécheur, E. I. (2006) Hepatitis C Virus Glycoproteins Mediate Low pH-dependent Membrane Fusion with Liposomes, J. Biol. Chem. 281, 3909-3917.
17. Ladokhin, A. S., Jayasinghe, S., and White, S. H. (2000) How to measure and analyze tryptophan fluorescence in membranes properly, and why bother? Anal. Biochem. 285, 235-245.
18. Pécheur, E. I., Martin, I., Ruysschaert, J. M., Bienvenue, A., and Hoekstra, D. (1998) Membrane fusion induced by 11-mer anionic and cationic peptides: A structure-function study, Biochemistry 37, 2361-2371.
19. 2+-induced fusion of phospholipid vesicles monitored by mixing of aqueous contents, Nature 281, 690-692.
20. Breisblatt, W., and Ohki, S. (1976) Fusion in phospholipid spherical membranes. II. Effect of cholesterol, divalent ions and pH, J. Membr. Biol. 29, 127-146.
21. Savarino, A., Boelaert, J. R., Cassone, A., Majori, G., and Cauda, R. (2003) Effects of chloroquine on viral infections: An old drug against today's diseases? Lancet Infect. Dis. 3, 722-727.
22. Hinman, R. L., and Lang, J. (1964) The Protonation of Indoles. Basicity Studies. The Dependence of Acidity Functions on Indicator Structure, J. Am. Chem. Soc. 86, 3796-3806.
23. Stegmann, T., Hoekstra, D., Scherphof, G., and Wilschut, J. (1985) Kinetics of pH-dependent fusion between influenza virus and liposomes, Biochemistry 24, 3107-3113.
24. Kobayashi, M., Bennett, M. C., Bercot, T., and Singh, I. R. (2006) Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay, J. Virol. 80, 1817-1825.
25. Petersen, F. N., Jensen, M. O., and Nielsen, C. H. (2005) Interfacial tryptophan residues: A role for the cation-π effect? Biophys. J. 89, 3985-3996.
26. Yau, W. M., Wimley, W. C., Gawrisch, K., and White, S. H. (1998) The preference of tryptophan for membrane interfaces, Biochemistry 37, 14713-14718.
27. Zacharias, N., and Dougherty, D. A. (2002) Cation-π interactions in ligand recognition and catalysis, Trends Pharmacol. Sci. 23, 281-287.
28. le Maire, M., Champeil, P., and Moller, J. V. (2000) Interaction of membrane proteins and lipids with solubilizing detergents, Biochim. Biophys. Acta 1508, 86-111.
29. Bartenschlager, R., and Lohmann, V. (2000) Replication of hepatitis C virus, J. Gen. Virol. 81, 1631-1648.
30. Lindenbach, B. D., and Rice, C. M. (2005) Unravelling hepatitis C virus replication from genome to function, Nature 436, 933-938.
31. Bartosch, B., and Cosset, F. L. (2006) Cell entry of hepatitis C virus, Virology 348, 1-12.
32. Bartosch, B., Vitelli, A., Granier, C., Goujon, C., Dubuisson, J., Pascale, S., Scarselli, E., Cortese, R., Nicosia, A., and Cosset, F. L. (2003) Cell Entry of Hepatitis C Virus Requires a Set of Coreceptors That Include the CD81 Tetraspanin and the SR-B1 Scavenger Receptor, J. Biol. Chem. 278, 41624-41630.
33. Tscherne, D. M., Jones, C. T., Evans, M. J., Lindenbach, B. D., McKeating, J. A., and Rice, C. M. (2006) Time- and temperature-dependent activation of hepatitis C virus for low-pH-triggered entry, J. Virol. 80, 1734-1741.
34. Kumar, V. V., and Baumann, W. J. (1991) Lanthanide-induced phosphorus-31 NMR downfield chemical shifts of lysophosphatidylcholines are sensitive to lysophospholipid critical micelle concentration, Biophys. J. 59, 103-107.
35. Tortech, L., Jaxel, C., Vincent, M., Gallay, J., and de Foresta, B. (2001) The polar headgroup of the detergent governs the accessibility to water of tryptophan octyl ester in host micelles, Biochim. Biophys. Acta 1514, 76-86.
36. de Foresta, B., Gallay, J., Sopkova, J., Champeil, P., and Vincent, M. (1999) Tryptophan octyl ester in detergent micelles of dodecylmaltoside: Fluorescence properties and quenching by brominated detergent analogs, Biophys. J. 77, 3071-3084.
37. Yeagle, P. L., Dentino, A. R., Smith, F. T., Spooner, P., and Watts, A. (1993) The antiviral peptide carbobenzoxy-D-phenylalanyl-L- phenylalanylglycine changes the average conformation of phospholipids in membranes, Biochemistry 32, 12197-12202.
38. Epand, R. M., Epand, R. F., Richardson, C. D., and Yeagle, P. L. (1993) Structural requirements for the inhibition of membrane fusion by carbobenzoxy-D-Phe-Phe-Gly, Biochim. Biophys. Acta 1152, 128-134.
39. Dentino, A. R., Westerman, P. W., and Yeagle, P. L. (1995) A study of carbobenzoxy-D-phenylalanine-L-phenylalanine-glycine, an inhibitor of membrane fusion, in phospholipid bilayers with multinuclear magnetic resonance, Biochim. Biophys. Acta 1235, 213-220.
40. Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T., and Lemon, S. M. (2006) Production of infectious genotype la hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells, Proc. Natl. Acad. Sci. U.S.A. 103, 2310-2315.
41. Pietschmann, T., Kaul, A., Koutsoudakis, G., Shavinskaya, A., Kallis, S., Steinmann, E., Abid, K., Negro, F., Dreux, M., Cosset, F. L., and Bartenschlager, R. (2006) Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras, Proc. Natl. Acad. Sci. U.S.A. 103, 7408-7413.
42. Moradpour, D., Gosert, R., Egger, D., Penin, F., Blum, H. E., and Bienz, K. (2003) Membrane association of hepatitis C virus nonstructural proteins and identification of the membrane alteration that harbors the viral replication complex, Antiviral Res. 60, 103-109.
43. Appel, N., Schaller, T., Penin, F., and Bartenschlager, R. (2006) From structure to function: New insights into hepatitis C virus RNA replication, J. Biol. Chem. 281, 9833-9836.
44. Gretton, S. N., Taylor, A. I., and McLauchlan, J. (2005) Mobility of the hepatitis C virus NS4B protein on the endoplasmic reticulum membrane and membrane-associated foci, J. Gen. Virol. 86, 1415-1421.
45. Feld, J. J., and Hoofnagle, J. H. (2005) Mechanism of action of interferon and ribavirin in treatment of hepatitis C, Nature 436, 967-972.
46. De Francesco, R., and Migliaccio, G. (2005) Challenges and successes in developing new therapies for hepatitis C, Nature 436, 953-960.
47. Sakamoto, H., Okamoto, K., Aoki, M., Kato, H., Katsume, A., Ohta, A., Tsukuda, T., Shimma, N., Aoki, Y., Arisawa, M., Kohara, M., and Sudoh, M. (2005) Host sphingolipid biosynthesis as a target for hepatitis C virus therapy, Nat. Chem. Biol. 1, 333-337.
48. Rakic, B., Sagan, S. M., Noestheden, M., Belanger, S., Nan, X., Evans, C. L., Xie, X. S., and Pezacki, J. P. (2006) Peroxisome proliferator-activated receptor α antagonism inhibits hepatitis C virus replication, Chem. Biol. 13, 23-30.